THU173 Subanalysis By Tanner Stage In Phase 3 Trials In Children And Adolescents With Growth Hormone Deficiency Treated With Lonapegsomatropin

Disclosure: P. Hofman: Speaker; Self; Novo Nordisk, Eli Lilly & Company. P.S. Thornton: Research Investigator; Self; Ascendis, Pfizer, Inc., Opko, Zealand, Rezolute, Spruce. Other; Self; Johnson &Johnson, Rezolute. U.M. Nadgir: None. P. Saenger: None. E. Chertok: None. E.M. Aghajanova: Speak...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofman, Paul, Thornton, Paul S, Nadgir, Ulhas M, Saenger, Paul, Chertok, Elena, Aghajanova, Elena M, Mao, Meng, Zhao, Carol, Ochoa-Maya, Margarita R, Komirenko, Allison, Shu, Aimee D, Maniatis, Aristides K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Pediatric Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555809/
http://dx.doi.org/10.1210/jendso/bvad114.1424

Ejemplares similares

Ejemplares similares